Description
CJC-1295 no DAC 10 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide supplied as a 10 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
“CJC1295 no DAC” is a catalogue name for modified GRF(1–29) (tetrasubstituted GHRH fragment) without the Drug Affinity Complex used on some longer CJC-1295 constructs. Confirm the exact sequence on the lot COA. This vial is not CJC-1295 with DAC unless the COA says so.
Identification
| Product name | CJC-1295 no DAC |
| Also listed as | Modified GRF(1–29); Mod GRF 1–29 |
| Supplier | Opti-Gen Peptides |
| Contents | 10 mg per vial |
| Class | Synthetic GHRH(1–29) analogue |
| Intended use | Laboratory / in-vitro research only |
Not sermorelin, tesamorelin, or CJC1295 with DAC.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.
Published research context (not product claims)
Modified GRF(1–29) is used in literature as a GHRH-receptor research ligand. Substitutions versus native GRF(1–29) are discussed for peptide stability in assay systems. Separate papers describe CJC-1295 with DAC as a longer-acting construct. Those studies are experimental and are not growth-hormone or body-composition claims for this vial.
GHRH analogues may be WADA-restricted in sport. There is no UK marketing authorisation for this listing.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.